CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis.
Francesco VitaliMatteo SerenelliKari Eino Juhani AiraksinenRita PavasiniAnna Tomaszuk-KazberukElzbieta MlodawskaSamuli JaakkolaCristina BallaLorenzo FalsettiNicola TarquinioRoberto FerrariAngelo SqueriGianluca CampoMatteo BertiniPublished in: Clinical cardiology (2019)
CHA2DS2-VASc score predicts early recurrence of AF in the first 30 days after electrical or pharmacological cardioversion. Protocol registration PROSPERO (CRD42017075107).
Keyphrases
- atrial fibrillation
- systematic review
- meta analyses
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- randomized controlled trial
- heart failure
- percutaneous coronary intervention
- case report
- free survival
- coronary artery disease
- acute coronary syndrome
- left ventricular
- study protocol